REGENXBIO Inc.
RGNX
Transaktioner
543
Köp
293
Sälj
250
Nettoinsynsflöde
-47.4 mn USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
1000 dagliga stängningskurserAvkastning efter transaktion
Median-% efter transaktionsdatum| Horisont | Efter köp | Efter sälj | Spridning | Träffsäkerhet köp |
|---|---|---|---|---|
| 1 handelsdagar | 2,11% (293) | 2,11% (250) | 0,00 pp | 62% |
| 5 handelsdagar | −2,47% (287) | −2,47% (250) | 0,00 pp | 24% |
| 30 handelsdagar | −13,78% (287) | −13,78% (246) | 0,00 pp | 12% |
| 90 handelsdagar | −11,35% (263) | −11,35% (236) | 0,00 pp | 11% |
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning0,02
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 30 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
543 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2026-08-27 | Ciongoli Gregory Austin | Director | Buy | 53 k | 9,36 | 500 k USD |
| 2026-08-27 | Ciongoli Gregory Austin | Director | Buy | 53 k | 9,36 | 500 k USD |
| 2026-08-26 | Ciongoli Gregory Austin | Director | Buy | 49 k | 9,14 | 450 k USD |
| 2026-08-26 | Ciongoli Gregory Austin | Director | Buy | 49 k | 9,14 | 450 k USD |
| 2026-08-25 | Ciongoli Gregory Austin | Director | Buy | 15 k | 0,00 | 0 USD |
| 2026-08-25 | Ciongoli Gregory Austin | Director | Buy | 15 k | 0,00 | 0 USD |
| 2026-08-01 | Christmas Patrick J. | Chief Strategy & Legal Officer | Sell | 5 k | 9,69 | 46 k USD |
| 2026-08-01 | PAKOLA STEVE | Chief Medical Officer | Sell | 7 k | 9,69 | 72 k USD |
| 2026-08-01 | Christmas Patrick J. | Chief Strategy & Legal Officer | Sell | 5 k | 9,69 | 46 k USD |
| 2026-08-01 | PAKOLA STEVE | Chief Medical Officer | Sell | 7 k | 9,69 | 72 k USD |
| 2026-07-02 | PAKOLA STEVE | Chief Medical Officer | Buy | 2 k | 7,86 | 17 k USD |
| 2026-07-02 | PAKOLA STEVE | Chief Medical Officer | Sell | 2 k | 13,64 | 29 k USD |
| 2026-07-02 | PAKOLA STEVE | Chief Medical Officer | Buy | 2 k | 7,86 | 17 k USD |
| 2026-07-02 | PAKOLA STEVE | Chief Medical Officer | Sell | 2 k | 13,64 | 29 k USD |
| 2026-07-01 | Simpson Curran | Chief Executive Officer | Sell | 7 k | 13,09 | 89 k USD |
| 2026-07-01 | Simpson Curran | Chief Executive Officer | Sell | 7 k | 13,09 | 89 k USD |
| 2026-07-01 | PAKOLA STEVE | Chief Medical Officer | Buy | 37 k | 7,86 | 289 k USD |
| 2026-07-01 | PAKOLA STEVE | Chief Medical Officer | Sell | 37 k | 12,86 | 472 k USD |
| 2026-07-01 | PAKOLA STEVE | Chief Medical Officer | Buy | 37 k | 7,86 | 289 k USD |
| 2026-07-01 | PAKOLA STEVE | Chief Medical Officer | Sell | 37 k | 12,86 | 472 k USD |
| 2026-06-30 | Simpson Curran | Chief Executive Officer | Buy | 1 k | 10,18 | 15 k USD |
| 2026-06-30 | Simpson Curran | Chief Executive Officer | Buy | 1 k | 10,18 | 15 k USD |
| 2026-06-29 | PAKOLA STEVE | Chief Medical Officer | Sell | 20 k | 11,04 | 216 k USD |
| 2026-06-29 | PAKOLA STEVE | Chief Medical Officer | Sell | 20 k | 11,04 | 216 k USD |
| 2026-05-29 | Bennett Jean | Director | Buy | 10 k | 0,00 | 0 USD |
| 2026-05-29 | Fox Allan M. | Director | Buy | 10 k | 0,00 | 0 USD |
| 2026-05-29 | Glucksmann Alexandra | Director | Buy | 10 k | 0,00 | 0 USD |
| 2026-05-29 | KARABELAS ARGERIS N | Director | Buy | 10 k | 0,00 | 0 USD |
| 2026-05-29 | MIGAUSKY GEORGE V | Director | Buy | 10 k | 0,00 | 0 USD |
| 2026-05-29 | Mills Kenneth T. | Director | Buy | 10 k | 0,00 | 0 USD |
| 2026-05-29 | MIGAUSKY GEORGE V | Director | Buy | 10 k | 0,00 | 0 USD |
| 2026-05-29 | KARABELAS ARGERIS N | Director | Buy | 10 k | 0,00 | 0 USD |
| 2026-05-29 | STUMP DAVID C | Director | Buy | 10 k | 0,00 | 0 USD |
| 2026-05-29 | Tasse Daniel | Director | Buy | 10 k | 0,00 | 0 USD |
| 2026-05-29 | Mills Kenneth T. | Director | Buy | 10 k | 0,00 | 0 USD |
| 2026-05-29 | Fox Allan M. | Director | Buy | 10 k | 0,00 | 0 USD |
| 2026-05-29 | Glucksmann Alexandra | Director | Buy | 10 k | 0,00 | 0 USD |
| 2026-05-29 | Zachary Jennifer | Director | Buy | 10 k | 0,00 | 0 USD |
| 2026-05-29 | Bennett Jean | Director | Buy | 10 k | 0,00 | 0 USD |
| 2026-05-29 | STUMP DAVID C | Director | Buy | 10 k | 0,00 | 0 USD |
| 2026-05-29 | Tasse Daniel | Director | Buy | 10 k | 0,00 | 0 USD |
| 2026-05-29 | Zachary Jennifer | Director | Buy | 10 k | 0,00 | 0 USD |
| 2026-05-11 | PAKOLA STEVE | Chief Medical Officer | Sell | 15 k | 11,02 | 169 k USD |
| 2026-05-11 | PAKOLA STEVE | Chief Medical Officer | Sell | 15 k | 11,02 | 169 k USD |
| 2026-03-10 | PAKOLA STEVE | Chief Medical Officer | Sell | 5 k | 10,35 | 53 k USD |
| 2026-03-10 | PAKOLA STEVE | Chief Medical Officer | Sell | 5 k | 10,35 | 53 k USD |
| 2026-02-01 | Christmas Patrick J. | Chief Strategy & Legal Officer | Sell | 5 k | 11,16 | 52 k USD |
| 2026-02-01 | PAKOLA STEVE | Chief Medical Officer | Sell | 5 k | 11,16 | 59 k USD |
| 2026-02-01 | Christmas Patrick J. | Chief Strategy & Legal Officer | Sell | 5 k | 11,16 | 52 k USD |
| 2026-02-01 | PAKOLA STEVE | Chief Medical Officer | Sell | 5 k | 11,16 | 59 k USD |
| 2026-01-27 | Mills Kenneth T. | Director | Buy | 225 k | 13,09 | 2.9 mn USD |
| 2026-01-27 | Mills Kenneth T. | Director | Sell | 222 k | 13,41 | 3.0 mn USD |
| 2026-01-27 | Mills Kenneth T. | Director | Buy | 225 k | 13,09 | 2.9 mn USD |
| 2026-01-27 | Mills Kenneth T. | Director | Sell | 222 k | 13,41 | 3.0 mn USD |
| 2026-01-06 | Chan Mitchell | Chief Financial Officer | Buy | 74 k | 0,00 | 0 USD |
| 2026-01-06 | Christmas Patrick J. | Chief Strategy & Legal Officer | Buy | 74 k | 0,00 | 0 USD |
| 2026-01-06 | Malzahn Craig | Chief Technology Officer | Buy | 66 k | 0,00 | 0 USD |
| 2026-01-06 | PAKOLA STEVE | Chief Medical Officer | Buy | 66 k | 0,00 | 0 USD |
| 2026-01-06 | Simpson Curran | Chief Executive Officer | Buy | 145 k | 0,00 | 0 USD |
| 2026-01-06 | Christmas Patrick J. | Chief Strategy & Legal Officer | Buy | 74 k | 0,00 | 0 USD |
| 2026-01-06 | PAKOLA STEVE | Chief Medical Officer | Buy | 66 k | 0,00 | 0 USD |
| 2026-01-06 | Chan Mitchell | Chief Financial Officer | Buy | 74 k | 0,00 | 0 USD |
| 2026-01-06 | Malzahn Craig | Chief Technology Officer | Buy | 66 k | 0,00 | 0 USD |
| 2026-01-06 | Simpson Curran | Chief Executive Officer | Buy | 145 k | 0,00 | 0 USD |
| 2026-01-02 | Christmas Patrick J. | Chief Strategy & Legal Officer | Sell | 10 k | 14,40 | 141 k USD |
| 2026-01-02 | Malzahn Craig | Chief Technology Officer | Sell | 1 k | 14,40 | 18 k USD |
| 2026-01-02 | PAKOLA STEVE | Chief Medical Officer | Sell | 18 k | 14,40 | 263 k USD |
| 2026-01-02 | Simpson Curran | Chief Executive Officer | Sell | 19 k | 14,40 | 267 k USD |
| 2026-01-02 | Christmas Patrick J. | Chief Strategy & Legal Officer | Sell | 10 k | 14,40 | 141 k USD |
| 2026-01-02 | PAKOLA STEVE | Chief Medical Officer | Sell | 18 k | 14,40 | 263 k USD |
| 2026-01-02 | Malzahn Craig | Chief Technology Officer | Sell | 1 k | 14,40 | 18 k USD |
| 2026-01-02 | Simpson Curran | Chief Executive Officer | Sell | 19 k | 14,40 | 267 k USD |
| 2025-12-31 | Simpson Curran | Chief Executive Officer | Buy | 951 | 7,00 | 7 k USD |
| 2025-12-31 | Simpson Curran | Chief Executive Officer | Buy | 951 | 7,00 | 7 k USD |
| 2025-10-09 | Simpson Curran | Chief Executive Officer | Sell | 21 k | 12,62 | 263 k USD |
| 2025-10-09 | Simpson Curran | Chief Executive Officer | Sell | 21 k | 12,62 | 263 k USD |
| 2025-09-29 | Simpson Curran | Chief Executive Officer | Sell | 8 k | 10,03 | 76 k USD |
| 2025-09-29 | Simpson Curran | Chief Executive Officer | Sell | 8 k | 10,03 | 76 k USD |
| 2025-09-10 | Simpson Curran | Chief Executive Officer | Sell | 8 k | 10,02 | 77 k USD |
| 2025-09-10 | Simpson Curran | Chief Executive Officer | Sell | 8 k | 10,02 | 77 k USD |
| 2025-09-01 | Chan Mitchell | Chief Financial Officer | Sell | 5 k | 8,93 | 44 k USD |
| 2025-09-01 | Malzahn Craig | Chief Technology Officer | Sell | 234 | 8,93 | 2 k USD |
| 2025-09-01 | Chan Mitchell | Chief Financial Officer | Sell | 5 k | 8,93 | 44 k USD |
| 2025-09-01 | Malzahn Craig | Chief Technology Officer | Sell | 234 | 8,93 | 2 k USD |
| 2025-08-01 | Christmas Patrick J. | Chief Strategy & Legal Officer | Sell | 5 k | 8,19 | 38 k USD |
| 2025-08-01 | Christmas Patrick J. | Chief Strategy & Legal Officer | Sell | 5 k | 8,19 | 38 k USD |
| 2025-07-01 | Simpson Curran | Chief Executive Officer | Sell | 5 k | 8,23 | 39 k USD |
| 2025-07-01 | Simpson Curran | Chief Executive Officer | Sell | 5 k | 8,23 | 39 k USD |
| 2025-05-30 | Bennett Jean | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-05-30 | Fox Allan M. | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-05-30 | Glucksmann Alexandra | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-05-30 | KARABELAS ARGERIS N | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-05-30 | MIGAUSKY GEORGE V | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-05-30 | Mills Kenneth T. | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-05-30 | Bennett Jean | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-05-30 | KARABELAS ARGERIS N | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-05-30 | Glucksmann Alexandra | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-05-30 | MIGAUSKY GEORGE V | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-05-30 | Mills Kenneth T. | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-05-30 | STUMP DAVID C | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-05-30 | Tasse Daniel | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-05-30 | Zachary Jennifer | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-05-30 | Fox Allan M. | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-05-30 | STUMP DAVID C | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-05-30 | Tasse Daniel | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-05-30 | Zachary Jennifer | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-05-12 | Mills Kenneth T. | Director | Buy | 21 k | 3,76 | 77 k USD |
| 2025-05-12 | Mills Kenneth T. | Director | Sell | 21 k | 7,91 | 163 k USD |
| 2025-05-12 | Mills Kenneth T. | Director | Buy | 21 k | 3,76 | 77 k USD |
| 2025-05-12 | Mills Kenneth T. | Director | Sell | 21 k | 7,91 | 163 k USD |
| 2025-03-27 | Mills Kenneth T. | Director | Buy | 31 k | 3,76 | 116 k USD |
| 2025-03-27 | Mills Kenneth T. | Director | Buy | 31 k | 3,76 | 116 k USD |
| 2025-02-01 | Christmas Patrick J. | Chief Legal Officer | Sell | 5 k | 8,07 | 38 k USD |
| 2025-02-01 | Danos Olivier | Chief Scientific Officer | Sell | 5 k | 8,07 | 44 k USD |
| 2025-02-01 | PAKOLA STEVE | Chief Medical Officer | Sell | 5 k | 8,07 | 42 k USD |
| 2025-02-01 | Danos Olivier | Chief Scientific Officer | Sell | 5 k | 8,07 | 44 k USD |
| 2025-02-01 | PAKOLA STEVE | Chief Medical Officer | Sell | 5 k | 8,07 | 42 k USD |
| 2025-02-01 | Christmas Patrick J. | Chief Legal Officer | Sell | 5 k | 8,07 | 38 k USD |
| 2025-01-02 | Christmas Patrick J. | Chief Legal Officer | Sell | 11 k | 7,73 | 88 k USD |
| 2025-01-02 | Danos Olivier | Chief Scientific Officer | Sell | 13 k | 7,73 | 98 k USD |
| 2025-01-02 | Danos Olivier | Chief Scientific Officer | Buy | 59 k | 0,00 | 0 USD |
| 2025-01-02 | PAKOLA STEVE | Chief Medical Officer | Sell | 14 k | 7,73 | 107 k USD |
| 2025-01-02 | PAKOLA STEVE | Chief Medical Officer | Buy | 64 k | 0,00 | 0 USD |
| 2025-01-02 | Christmas Patrick J. | Chief Legal Officer | Sell | 11 k | 7,73 | 88 k USD |
| 2025-01-02 | Simpson Curran | Chief Executive Officer | Sell | 12 k | 7,73 | 92 k USD |
| 2025-01-02 | Simpson Curran | Chief Executive Officer | Buy | 99 k | 0,00 | 0 USD |
| 2025-01-02 | Danos Olivier | Chief Scientific Officer | Sell | 13 k | 7,73 | 98 k USD |
| 2025-01-02 | Danos Olivier | Chief Scientific Officer | Buy | 59 k | 0,00 | 0 USD |
| 2025-01-02 | PAKOLA STEVE | Chief Medical Officer | Sell | 14 k | 7,73 | 107 k USD |
| 2025-01-02 | PAKOLA STEVE | Chief Medical Officer | Buy | 64 k | 0,00 | 0 USD |
| 2025-01-02 | Simpson Curran | Chief Executive Officer | Sell | 12 k | 7,73 | 92 k USD |
| 2025-01-02 | Simpson Curran | Chief Executive Officer | Buy | 99 k | 0,00 | 0 USD |
| 2024-10-01 | KARABELAS ARGERIS N | Director | Buy | 10 k | 3,76 | 38 k USD |
| 2024-10-01 | KARABELAS ARGERIS N | Director | Sell | 10 k | 10,11 | 101 k USD |
| 2024-10-01 | KARABELAS ARGERIS N | Director | Buy | 10 k | 3,76 | 38 k USD |
| 2024-10-01 | KARABELAS ARGERIS N | Director | Sell | 10 k | 10,11 | 101 k USD |
| 2024-09-16 | Chan Mitchell | Chief Financial Officer | Buy | 59 k | 0,00 | 0 USD |
| 2024-09-16 | Chan Mitchell | Chief Financial Officer | Buy | 59 k | 0,00 | 0 USD |
| 2024-09-03 | KARABELAS ARGERIS N | Director | Buy | 10 k | 3,76 | 38 k USD |
| 2024-09-03 | KARABELAS ARGERIS N | Director | Sell | 9 k | 11,50 | 107 k USD |
| 2024-09-03 | KARABELAS ARGERIS N | Director | Sell | 700 | 12,34 | 9 k USD |
| 2024-09-03 | KARABELAS ARGERIS N | Director | Buy | 10 k | 3,76 | 38 k USD |
| 2024-09-03 | KARABELAS ARGERIS N | Director | Sell | 9 k | 11,50 | 107 k USD |
| 2024-09-03 | KARABELAS ARGERIS N | Director | Sell | 700 | 12,34 | 9 k USD |
| 2024-08-08 | Mills Kenneth T. | Director | Buy | 36 k | 0,85 | 31 k USD |
| 2024-08-08 | Mills Kenneth T. | Director | Buy | 36 k | 0,85 | 31 k USD |
| 2024-08-01 | Christmas Patrick J. | Chief Legal Officer | Buy | 56 k | 0,00 | 0 USD |
| 2024-08-01 | Danos Olivier | Chief Scientific Officer | Buy | 59 k | 0,00 | 0 USD |
| 2024-08-01 | KARABELAS ARGERIS N | Director | Buy | 10 k | 3,76 | 38 k USD |
| 2024-08-01 | KARABELAS ARGERIS N | Director | Buy | 100 | 12,74 | 1 k USD |
| 2024-08-01 | KARABELAS ARGERIS N | Director | Sell | 10 k | 13,45 | 129 k USD |
| 2024-08-01 | KARABELAS ARGERIS N | Director | Sell | 400 | 14,59 | 6 k USD |
| 2024-08-01 | KARABELAS ARGERIS N | Director | Sell | 100 | 15,00 | 2 k USD |
| 2024-08-01 | PAKOLA STEVE | Chief Medical Officer | Buy | 58 k | 0,00 | 0 USD |
| 2024-08-01 | Danos Olivier | Chief Scientific Officer | Buy | 59 k | 0,00 | 0 USD |
| 2024-08-01 | Simpson Curran | Chief Executive Officer | Sell | 100 | 15,00 | 2 k USD |
| 2024-08-01 | KARABELAS ARGERIS N | Director | Buy | 10 k | 3,76 | 38 k USD |
| 2024-08-01 | KARABELAS ARGERIS N | Director | Buy | 100 | 12,74 | 1 k USD |
| 2024-08-01 | KARABELAS ARGERIS N | Director | Sell | 10 k | 13,45 | 129 k USD |
| 2024-08-01 | KARABELAS ARGERIS N | Director | Sell | 400 | 14,59 | 6 k USD |
| 2024-08-01 | KARABELAS ARGERIS N | Director | Sell | 100 | 15,00 | 2 k USD |
| 2024-08-01 | Christmas Patrick J. | Chief Legal Officer | Buy | 56 k | 0,00 | 0 USD |
| 2024-08-01 | PAKOLA STEVE | Chief Medical Officer | Buy | 58 k | 0,00 | 0 USD |
| 2024-08-01 | Simpson Curran | Chief Executive Officer | Sell | 100 | 15,00 | 2 k USD |
| 2024-07-29 | KARABELAS ARGERIS N | Director | Buy | 11 k | 12,74 | 140 k USD |
| 2024-07-29 | KARABELAS ARGERIS N | Director | Sell | 11 k | 15,05 | 165 k USD |
| 2024-07-29 | Simpson Curran | Chief Executive Officer | Sell | 10 k | 15,04 | 145 k USD |
| 2024-07-29 | KARABELAS ARGERIS N | Director | Buy | 11 k | 12,74 | 140 k USD |
| 2024-07-29 | KARABELAS ARGERIS N | Director | Sell | 11 k | 15,05 | 165 k USD |
| 2024-07-29 | Simpson Curran | Chief Executive Officer | Sell | 10 k | 15,04 | 145 k USD |
| 2024-07-25 | Mills Kenneth T. | Director | Buy | 15 k | 3,76 | 58 k USD |
| 2024-07-25 | Mills Kenneth T. | Director | Sell | 15 k | 13,96 | 215 k USD |
| 2024-07-25 | Mills Kenneth T. | Director | Buy | 15 k | 3,76 | 58 k USD |
| 2024-07-25 | Mills Kenneth T. | Director | Sell | 15 k | 13,96 | 215 k USD |
| 2024-07-24 | Mills Kenneth T. | Director | Buy | 12 k | 3,76 | 46 k USD |
| 2024-07-24 | Mills Kenneth T. | Director | Sell | 12 k | 13,78 | 168 k USD |
| 2024-07-24 | Mills Kenneth T. | Director | Buy | 12 k | 3,76 | 46 k USD |
| 2024-07-24 | Mills Kenneth T. | Director | Sell | 12 k | 13,78 | 168 k USD |
| 2024-07-17 | Mills Kenneth T. | Director | Buy | 2 k | 3,76 | 8 k USD |
| 2024-07-17 | Mills Kenneth T. | Director | Sell | 2 k | 13,77 | 30 k USD |
| 2024-07-17 | Mills Kenneth T. | Director | Buy | 2 k | 3,76 | 8 k USD |
| 2024-07-17 | Mills Kenneth T. | Director | Sell | 2 k | 13,77 | 30 k USD |
| 2024-07-16 | Mills Kenneth T. | Director | Buy | 200 | 3,76 | 752 USD |
| 2024-07-16 | Mills Kenneth T. | Director | Sell | 200 | 13,76 | 3 k USD |
| 2024-07-16 | Mills Kenneth T. | Director | Buy | 200 | 3,76 | 752 USD |
| 2024-07-16 | Mills Kenneth T. | Director | Sell | 200 | 13,76 | 3 k USD |
| 2024-07-01 | KARABELAS ARGERIS N | Director | Buy | 10 k | 3,76 | 38 k USD |
| 2024-07-01 | KARABELAS ARGERIS N | Director | Sell | 10 k | 11,27 | 113 k USD |
| 2024-07-01 | KARABELAS ARGERIS N | Director | Buy | 10 k | 3,76 | 38 k USD |
| 2024-07-01 | KARABELAS ARGERIS N | Director | Sell | 10 k | 11,27 | 113 k USD |
| 2024-07-01 | Simpson Curran | Chief Executive Officer | Buy | 56 k | 0,00 | 0 USD |
| 2024-07-01 | Simpson Curran | Chief Executive Officer | Buy | 56 k | 0,00 | 0 USD |
| 2024-06-28 | Danos Olivier | Chief Scientific Officer | Buy | 1 k | 9,95 | 14 k USD |
| 2024-06-28 | Danos Olivier | Chief Scientific Officer | Buy | 1 k | 9,95 | 14 k USD |
| 2024-05-31 | Bennett Jean | Director | Buy | 5 k | 0,00 | 0 USD |
| 2024-05-31 | Fox Allan M. | Director | Buy | 5 k | 0,00 | 0 USD |
| 2024-05-31 | Glucksmann Alexandra | Director | Buy | 5 k | 0,00 | 0 USD |
| 2024-05-31 | KARABELAS ARGERIS N | Director | Buy | 5 k | 0,00 | 0 USD |
| 2024-05-31 | MIGAUSKY GEORGE V | Director | Buy | 5 k | 0,00 | 0 USD |
| 2024-05-31 | STUMP DAVID C | Director | Buy | 5 k | 0,00 | 0 USD |
| 2024-05-31 | Tasse Daniel | Director | Buy | 5 k | 0,00 | 0 USD |
| 2024-05-31 | Fox Allan M. | Director | Buy | 5 k | 0,00 | 0 USD |
| 2024-05-31 | Bennett Jean | Director | Buy | 5 k | 0,00 | 0 USD |
| 2024-05-31 | Glucksmann Alexandra | Director | Buy | 5 k | 0,00 | 0 USD |
| 2024-05-31 | KARABELAS ARGERIS N | Director | Buy | 5 k | 0,00 | 0 USD |
| 2024-05-31 | MIGAUSKY GEORGE V | Director | Buy | 5 k | 0,00 | 0 USD |
| 2024-05-31 | Zachary Jennifer | Director | Buy | 5 k | 0,00 | 0 USD |
| 2024-05-31 | STUMP DAVID C | Director | Buy | 5 k | 0,00 | 0 USD |
| 2024-05-31 | Tasse Daniel | Director | Buy | 5 k | 0,00 | 0 USD |
| 2024-05-31 | Zachary Jennifer | Director | Buy | 5 k | 0,00 | 0 USD |
| 2024-05-14 | Mills Kenneth T. | President and CEO | Buy | 15 k | 3,76 | 56 k USD |
| 2024-05-14 | Mills Kenneth T. | President and CEO | Sell | 15 k | 15,81 | 237 k USD |
| 2024-05-14 | Mills Kenneth T. | President and CEO | Buy | 15 k | 3,76 | 56 k USD |
| 2024-05-14 | Mills Kenneth T. | President and CEO | Sell | 15 k | 15,81 | 237 k USD |
| 2024-04-15 | Mills Kenneth T. | President and CEO | Buy | 15 k | 3,76 | 56 k USD |
| 2024-04-15 | Mills Kenneth T. | President and CEO | Sell | 15 k | 18,19 | 273 k USD |
| 2024-04-15 | Mills Kenneth T. | President and CEO | Buy | 15 k | 3,76 | 56 k USD |
| 2024-04-15 | Mills Kenneth T. | President and CEO | Sell | 15 k | 18,19 | 273 k USD |
| 2024-03-19 | Vasista Vittal | Chief Financial Officer | Buy | 20 k | 3,76 | 75 k USD |
| 2024-03-19 | Vasista Vittal | Chief Financial Officer | Buy | 20 k | 3,76 | 75 k USD |
| 2024-03-14 | Mills Kenneth T. | President and CEO | Buy | 15 k | 3,76 | 56 k USD |
| 2024-03-14 | Mills Kenneth T. | President and CEO | Sell | 15 k | 21,86 | 328 k USD |
| 2024-03-14 | Mills Kenneth T. | President and CEO | Sell | 15 k | 21,86 | 328 k USD |
| 2024-03-14 | Mills Kenneth T. | President and CEO | Buy | 15 k | 3,76 | 56 k USD |
| 2024-03-05 | PAKOLA STEVE | Chief Medical Officer | Buy | 13 k | 22,25 | 287 k USD |
| 2024-03-05 | PAKOLA STEVE | Chief Medical Officer | Sell | 13 k | 28,36 | 365 k USD |
| 2024-03-05 | PAKOLA STEVE | Chief Medical Officer | Buy | 13 k | 22,25 | 287 k USD |
| 2024-03-05 | PAKOLA STEVE | Chief Medical Officer | Sell | 13 k | 28,36 | 365 k USD |
| 2024-02-14 | Mills Kenneth T. | President and CEO | Buy | 15 k | 3,76 | 56 k USD |
| 2024-02-14 | Mills Kenneth T. | President and CEO | Sell | 5 k | 16,47 | 77 k USD |
| 2024-02-14 | Mills Kenneth T. | President and CEO | Sell | 10 k | 16,88 | 175 k USD |
| 2024-02-14 | Mills Kenneth T. | President and CEO | Buy | 15 k | 3,76 | 56 k USD |
| 2024-02-14 | Mills Kenneth T. | President and CEO | Sell | 5 k | 16,47 | 77 k USD |
| 2024-02-14 | Mills Kenneth T. | President and CEO | Sell | 10 k | 16,88 | 175 k USD |
| 2024-01-16 | Mills Kenneth T. | President and CEO | Buy | 45 k | 3,76 | 169 k USD |
| 2024-01-16 | Mills Kenneth T. | President and CEO | Sell | 45 k | 15,18 | 683 k USD |
| 2024-01-16 | Mills Kenneth T. | President and CEO | Buy | 45 k | 3,76 | 169 k USD |
| 2024-01-16 | Mills Kenneth T. | President and CEO | Sell | 45 k | 15,18 | 683 k USD |
| 2024-01-03 | PAKOLA STEVE | Chief Medical Officer | Sell | 17 k | 17,39 | 300 k USD |
| 2024-01-03 | PAKOLA STEVE | Chief Medical Officer | Sell | 17 k | 17,39 | 300 k USD |
| 2024-01-02 | Christmas Patrick J. | Chief Legal Officer | Buy | 35 k | 0,00 | 0 USD |
| 2024-01-02 | Christmas Patrick J. | Chief Legal Officer | Sell | 8 k | 17,95 | 142 k USD |
| 2024-01-02 | Danos Olivier | Chief Scientific Officer | Sell | 8 k | 17,95 | 151 k USD |
| 2024-01-02 | Danos Olivier | Chief Scientific Officer | Buy | 38 k | 0,00 | 0 USD |
| 2024-01-02 | Mills Kenneth T. | President and CEO | Sell | 11 k | 17,95 | 204 k USD |
| 2024-01-02 | Mills Kenneth T. | President and CEO | Buy | 64 k | 0,00 | 0 USD |
| 2024-01-02 | PAKOLA STEVE | Chief Medical Officer | Sell | 10 k | 17,95 | 186 k USD |
| 2024-01-02 | PAKOLA STEVE | Chief Medical Officer | Buy | 32 k | 0,00 | 0 USD |
| 2024-01-02 | Christmas Patrick J. | Chief Legal Officer | Sell | 8 k | 17,95 | 142 k USD |
| 2024-01-02 | Christmas Patrick J. | Chief Legal Officer | Buy | 35 k | 0,00 | 0 USD |
| 2024-01-02 | Mills Kenneth T. | President and CEO | Sell | 11 k | 17,95 | 204 k USD |
| 2024-01-02 | Mills Kenneth T. | President and CEO | Buy | 64 k | 0,00 | 0 USD |
| 2024-01-02 | Vasista Vittal | Chief Financial Officer | Sell | 5 k | 17,95 | 81 k USD |
| 2024-01-02 | Vasista Vittal | Chief Financial Officer | Buy | 16 k | 0,00 | 0 USD |
| 2024-01-02 | Danos Olivier | Chief Scientific Officer | Sell | 8 k | 17,95 | 151 k USD |
| 2024-01-02 | Danos Olivier | Chief Scientific Officer | Buy | 38 k | 0,00 | 0 USD |
| 2024-01-02 | PAKOLA STEVE | Chief Medical Officer | Sell | 10 k | 17,95 | 186 k USD |
| 2024-01-02 | PAKOLA STEVE | Chief Medical Officer | Buy | 32 k | 0,00 | 0 USD |
| 2024-01-02 | Simpson Curran | Chief Oper. & Tech. Officer | Sell | 8 k | 17,95 | 146 k USD |
| 2024-01-02 | Simpson Curran | Chief Oper. & Tech. Officer | Buy | 38 k | 0,00 | 0 USD |
| 2024-01-02 | Simpson Curran | Chief Oper. & Tech. Officer | Sell | 8 k | 17,95 | 146 k USD |
| 2024-01-02 | Simpson Curran | Chief Oper. & Tech. Officer | Buy | 38 k | 0,00 | 0 USD |
| 2024-01-02 | Vasista Vittal | Chief Financial Officer | Sell | 5 k | 17,95 | 81 k USD |
| 2024-01-02 | Vasista Vittal | Chief Financial Officer | Buy | 16 k | 0,00 | 0 USD |
| 2023-12-19 | Mills Kenneth T. | President and CEO | Buy | 44 k | 3,76 | 164 k USD |
| 2023-12-19 | Mills Kenneth T. | President and CEO | Buy | 2 k | 0,85 | 1 k USD |
| 2023-12-19 | Mills Kenneth T. | President and CEO | Sell | 45 k | 19,69 | 886 k USD |
| 2023-12-19 | Mills Kenneth T. | President and CEO | Buy | 44 k | 3,76 | 164 k USD |
| 2023-12-19 | Mills Kenneth T. | President and CEO | Buy | 2 k | 0,85 | 1 k USD |
| 2023-12-19 | Mills Kenneth T. | President and CEO | Sell | 45 k | 19,69 | 886 k USD |
| 2023-06-30 | Danos Olivier | Chief Scientific Officer | Buy | 1 k | 16,99 | 19 k USD |
| 2023-06-30 | Danos Olivier | Chief Scientific Officer | Buy | 1 k | 16,99 | 19 k USD |
| 2023-06-02 | Bennett Jean | Director | Buy | 3 k | 0,00 | 0 USD |
| 2023-06-02 | Fox Allan M. | Director | Buy | 3 k | 0,00 | 0 USD |
| 2023-06-02 | Glucksmann Alexandra | Director | Buy | 3 k | 0,00 | 0 USD |
| 2023-06-02 | KARABELAS ARGERIS N | Director | Buy | 3 k | 0,00 | 0 USD |
| 2023-06-02 | MIGAUSKY GEORGE V | Director | Buy | 3 k | 0,00 | 0 USD |
| 2023-06-02 | Zachary Jennifer | Director | Buy | 3 k | 0,00 | 0 USD |
| 2023-06-02 | Bennett Jean | Director | Buy | 3 k | 0,00 | 0 USD |
| 2023-06-02 | KARABELAS ARGERIS N | Director | Buy | 3 k | 0,00 | 0 USD |
| 2023-06-02 | Glucksmann Alexandra | Director | Buy | 3 k | 0,00 | 0 USD |
| 2023-06-02 | MIGAUSKY GEORGE V | Director | Buy | 3 k | 0,00 | 0 USD |
| 2023-06-02 | STUMP DAVID C | Director | Buy | 3 k | 0,00 | 0 USD |
| 2023-06-02 | Tasse Daniel | Director | Buy | 3 k | 0,00 | 0 USD |
| 2023-06-02 | Fox Allan M. | Director | Buy | 3 k | 0,00 | 0 USD |
| 2023-06-02 | STUMP DAVID C | Director | Buy | 3 k | 0,00 | 0 USD |
| 2023-06-02 | Zachary Jennifer | Director | Buy | 3 k | 0,00 | 0 USD |
| 2023-05-31 | Vasista Vittal | Chief Financial Officer | Buy | 35 k | 0,85 | 30 k USD |
| 2023-05-31 | Vasista Vittal | Chief Financial Officer | Buy | 35 k | 0,85 | 30 k USD |
| 2023-01-03 | Christmas Patrick J. | Chief Legal Officer | Sell | 2 k | 22,68 | 42 k USD |
| 2023-01-03 | Christmas Patrick J. | Chief Legal Officer | Buy | 68 k | 0,00 | 0 USD |
| 2023-01-03 | Danos Olivier | Chief Scientific Officer | Sell | 2 k | 22,68 | 47 k USD |
| 2023-01-03 | Danos Olivier | Chief Scientific Officer | Buy | 66 k | 0,00 | 0 USD |
| 2023-01-03 | Mills Kenneth T. | President and CEO | Sell | 9 k | 22,68 | 211 k USD |
| 2023-01-03 | Mills Kenneth T. | President and CEO | Buy | 55 k | 0,00 | 0 USD |
| 2023-01-03 | PAKOLA STEVE | Chief Medical Officer | Sell | 2 k | 22,68 | 42 k USD |
| 2023-01-03 | PAKOLA STEVE | Chief Medical Officer | Sell | 3 k | 22,17 | 70 k USD |
| 2023-01-03 | PAKOLA STEVE | Chief Medical Officer | Buy | 91 k | 0,00 | 0 USD |
| 2023-01-03 | Christmas Patrick J. | Chief Legal Officer | Sell | 2 k | 22,68 | 42 k USD |
| 2023-01-03 | Christmas Patrick J. | Chief Legal Officer | Buy | 68 k | 0,00 | 0 USD |
| 2023-01-03 | Danos Olivier | Chief Scientific Officer | Sell | 2 k | 22,68 | 47 k USD |
| 2023-01-03 | Danos Olivier | Chief Scientific Officer | Buy | 66 k | 0,00 | 0 USD |
| 2023-01-03 | Mills Kenneth T. | President and CEO | Sell | 9 k | 22,68 | 211 k USD |
| 2023-01-03 | Mills Kenneth T. | President and CEO | Buy | 55 k | 0,00 | 0 USD |
| 2023-01-03 | PAKOLA STEVE | Chief Medical Officer | Sell | 2 k | 22,68 | 42 k USD |
| 2023-01-03 | PAKOLA STEVE | Chief Medical Officer | Sell | 3 k | 22,17 | 70 k USD |
| 2023-01-03 | PAKOLA STEVE | Chief Medical Officer | Buy | 91 k | 0,00 | 0 USD |
| 2023-01-03 | Simpson Curran | Chief Oper. & Tech. Officer | Sell | 2 k | 22,68 | 47 k USD |
| 2023-01-03 | Simpson Curran | Chief Oper. & Tech. Officer | Buy | 68 k | 0,00 | 0 USD |
| 2023-01-03 | Vasista Vittal | Chief Financial Officer | Sell | 1 k | 22,68 | 30 k USD |
| 2023-01-03 | Vasista Vittal | Chief Financial Officer | Buy | 46 k | 0,00 | 0 USD |
| 2023-01-03 | Simpson Curran | Chief Oper. & Tech. Officer | Sell | 2 k | 22,68 | 47 k USD |
| 2023-01-03 | Simpson Curran | Chief Oper. & Tech. Officer | Buy | 68 k | 0,00 | 0 USD |
| 2023-01-03 | Vasista Vittal | Chief Financial Officer | Sell | 1 k | 22,68 | 30 k USD |
| 2023-01-03 | Vasista Vittal | Chief Financial Officer | Buy | 46 k | 0,00 | 0 USD |
| 2022-08-30 | Vasista Vittal | Chief Financial Officer | Sell | 2 k | 30,24 | 73 k USD |
| 2022-08-30 | Vasista Vittal | Chief Financial Officer | Sell | 2 k | 30,24 | 73 k USD |
| 2022-08-05 | Vasista Vittal | Chief Financial Officer | Sell | 17 k | 35,19 | 608 k USD |
| 2022-08-05 | Vasista Vittal | Chief Financial Officer | Sell | 17 k | 35,19 | 608 k USD |
| 2022-08-04 | Vasista Vittal | Chief Financial Officer | Sell | 400 | 35,00 | 14 k USD |
| 2022-08-04 | Vasista Vittal | Chief Financial Officer | Sell | 400 | 35,00 | 14 k USD |
| 2022-08-01 | Vasista Vittal | Chief Financial Officer | Sell | 2 k | 31,26 | 75 k USD |
| 2022-08-01 | Vasista Vittal | Chief Financial Officer | Sell | 2 k | 31,26 | 75 k USD |
| 2022-07-14 | Vasista Vittal | Chief Financial Officer | Sell | 468 | 30,00 | 14 k USD |
| 2022-07-14 | Vasista Vittal | Chief Financial Officer | Sell | 468 | 30,00 | 14 k USD |
| 2022-07-13 | Vasista Vittal | Chief Financial Officer | Sell | 4 k | 30,01 | 130 k USD |
| 2022-07-13 | Vasista Vittal | Chief Financial Officer | Sell | 4 k | 30,01 | 130 k USD |
| 2022-06-30 | Danos Olivier | Chief Scientific Officer | Buy | 728 | 21,00 | 15 k USD |
| 2022-06-30 | Danos Olivier | Chief Scientific Officer | Buy | 728 | 21,00 | 15 k USD |
| 2022-06-03 | Bennett Jean | Director | Buy | 3 k | 0,00 | 0 USD |
| 2022-06-03 | Fox Allan M. | Director | Buy | 3 k | 0,00 | 0 USD |
| 2022-06-03 | Glucksmann Alexandra | Director | Buy | 3 k | 0,00 | 0 USD |
| 2022-06-03 | KARABELAS ARGERIS N | Director | Buy | 3 k | 0,00 | 0 USD |
| 2022-06-03 | MIGAUSKY GEORGE V | Director | Buy | 3 k | 0,00 | 0 USD |
| 2022-06-03 | Bennett Jean | Director | Buy | 3 k | 0,00 | 0 USD |
| 2022-06-03 | Fox Allan M. | Director | Buy | 3 k | 0,00 | 0 USD |
| 2022-06-03 | Glucksmann Alexandra | Director | Buy | 3 k | 0,00 | 0 USD |
| 2022-06-03 | KARABELAS ARGERIS N | Director | Buy | 3 k | 0,00 | 0 USD |
| 2022-06-03 | MIGAUSKY GEORGE V | Director | Buy | 3 k | 0,00 | 0 USD |
| 2022-06-03 | STUMP DAVID C | Director | Buy | 3 k | 0,00 | 0 USD |
| 2022-06-03 | Tasse Daniel | Director | Buy | 3 k | 0,00 | 0 USD |
| 2022-06-03 | Zachary Jennifer | Director | Buy | 6 k | 0,00 | 0 USD |
| 2022-06-03 | STUMP DAVID C | Director | Buy | 3 k | 0,00 | 0 USD |
| 2022-06-03 | Tasse Daniel | Director | Buy | 3 k | 0,00 | 0 USD |
| 2022-06-03 | Zachary Jennifer | Director | Buy | 6 k | 0,00 | 0 USD |
| 2022-01-20 | Vasista Vittal | Chief Financial Officer | Buy | 30 k | 0,85 | 25 k USD |
| 2022-01-20 | Vasista Vittal | Chief Financial Officer | Buy | 30 k | 0,85 | 25 k USD |
| 2022-01-03 | Christmas Patrick J. | Chief Legal Officer | Buy | 8 k | 0,00 | 0 USD |
| 2022-01-03 | Danos Olivier | Chief Scientific Officer | Buy | 11 k | 0,00 | 0 USD |
| 2022-01-03 | Mills Kenneth T. | President and CEO | Buy | 36 k | 0,00 | 0 USD |
| 2022-01-03 | PAKOLA STEVE | Chief Medical Officer | Sell | 2 k | 33,75 | 54 k USD |
| 2022-01-03 | PAKOLA STEVE | Chief Medical Officer | Buy | 9 k | 0,00 | 0 USD |
| 2022-01-03 | Mills Kenneth T. | President and CEO | Buy | 36 k | 0,00 | 0 USD |
| 2022-01-03 | Christmas Patrick J. | Chief Legal Officer | Buy | 8 k | 0,00 | 0 USD |
| 2022-01-03 | Danos Olivier | Chief Scientific Officer | Buy | 11 k | 0,00 | 0 USD |
| 2022-01-03 | PAKOLA STEVE | Chief Medical Officer | Sell | 2 k | 33,75 | 54 k USD |
| 2022-01-03 | PAKOLA STEVE | Chief Medical Officer | Buy | 9 k | 0,00 | 0 USD |
| 2022-01-03 | Simpson Curran | Chief Oper. & Tech. Officer | Buy | 11 k | 0,00 | 0 USD |
| 2022-01-03 | Vasista Vittal | Chief Financial Officer | Buy | 9 k | 0,00 | 0 USD |
| 2022-01-03 | Simpson Curran | Chief Oper. & Tech. Officer | Buy | 11 k | 0,00 | 0 USD |
| 2022-01-03 | Vasista Vittal | Chief Financial Officer | Buy | 9 k | 0,00 | 0 USD |
| 2022-01-01 | Christmas Patrick J. | Chief Legal Officer | Sell | 1 k | 32,70 | 44 k USD |
| 2022-01-01 | Danos Olivier | Chief Scientific Officer | Sell | 1 k | 32,70 | 40 k USD |
| 2022-01-01 | Mills Kenneth T. | President and CEO | Sell | 4 k | 32,70 | 119 k USD |
| 2022-01-01 | PAKOLA STEVE | Chief Medical Officer | Sell | 1 k | 32,70 | 38 k USD |
| 2022-01-01 | Mills Kenneth T. | President and CEO | Sell | 4 k | 32,70 | 119 k USD |
| 2022-01-01 | Christmas Patrick J. | Chief Legal Officer | Sell | 1 k | 32,70 | 44 k USD |
| 2022-01-01 | Danos Olivier | Chief Scientific Officer | Sell | 1 k | 32,70 | 40 k USD |
| 2022-01-01 | PAKOLA STEVE | Chief Medical Officer | Sell | 1 k | 32,70 | 38 k USD |
| 2022-01-01 | Simpson Curran | Chief Oper. & Tech. Officer | Sell | 1 k | 32,70 | 44 k USD |
| 2022-01-01 | Simpson Curran | Chief Oper. & Tech. Officer | Sell | 1 k | 32,70 | 44 k USD |
| 2021-12-31 | Danos Olivier | Chief Scientific Officer | Buy | 1 | 27,80 | 28 USD |
| 2021-12-31 | Danos Olivier | Chief Scientific Officer | Buy | 1 | 27,80 | 28 USD |
| 2021-12-23 | Fox Allan M. | Director | Sell | 45 k | 34,92 | 1.6 mn USD |
| 2021-12-23 | Fox Allan M. | Director | Sell | 6 k | 35,85 | 227 k USD |
| 2021-12-23 | Fox Allan M. | Director | Sell | 45 k | 34,92 | 1.6 mn USD |
| 2021-12-23 | Fox Allan M. | Director | Sell | 6 k | 35,85 | 227 k USD |
| 2021-12-22 | Fox Allan M. | Director | Sell | 62 k | 34,40 | 2.1 mn USD |
| 2021-12-22 | Fox Allan M. | Director | Sell | 62 k | 34,40 | 2.1 mn USD |
| 2021-12-02 | Mills Kenneth T. | President and CEO | Sell | 3 k | 0,00 | 0 USD |
| 2021-12-02 | Mills Kenneth T. | President and CEO | Sell | 3 k | 0,00 | 0 USD |
| 2021-11-08 | Mills Kenneth T. | President and CEO | Buy | 2 k | 3,76 | 6 k USD |
| 2021-11-08 | Mills Kenneth T. | President and CEO | Sell | 2 k | 40,00 | 60 k USD |
| 2021-11-08 | Mills Kenneth T. | President and CEO | Buy | 2 k | 3,76 | 6 k USD |
| 2021-11-08 | Mills Kenneth T. | President and CEO | Sell | 2 k | 40,00 | 60 k USD |
| 2021-09-27 | Mills Kenneth T. | President and CEO | Buy | 2 k | 3,76 | 6 k USD |
| 2021-09-27 | Mills Kenneth T. | President and CEO | Sell | 2 k | 42,19 | 63 k USD |
| 2021-09-27 | Mills Kenneth T. | President and CEO | Buy | 2 k | 3,76 | 6 k USD |
| 2021-09-27 | Mills Kenneth T. | President and CEO | Sell | 2 k | 42,19 | 63 k USD |
| 2021-09-17 | Fox Allan M. | Director | Sell | 48 k | 45,04 | 2.2 mn USD |
| 2021-09-17 | Fox Allan M. | Director | Sell | 48 k | 45,04 | 2.2 mn USD |
| 2021-09-14 | Mills Kenneth T. | President and CEO | Buy | 33 k | 3,76 | 125 k USD |
| 2021-09-14 | Mills Kenneth T. | President and CEO | Buy | 2 k | 0,85 | 2 k USD |
| 2021-09-14 | Mills Kenneth T. | President and CEO | Sell | 35 k | 45,11 | 1.6 mn USD |
| 2021-09-14 | Mills Kenneth T. | President and CEO | Buy | 33 k | 3,76 | 125 k USD |
| 2021-09-14 | Mills Kenneth T. | President and CEO | Buy | 2 k | 0,85 | 2 k USD |
| 2021-09-14 | Mills Kenneth T. | President and CEO | Sell | 35 k | 45,11 | 1.6 mn USD |
| 2021-09-13 | Mills Kenneth T. | President and CEO | Buy | 3 k | 3,76 | 11 k USD |
| 2021-09-13 | Mills Kenneth T. | President and CEO | Sell | 3 k | 40,02 | 120 k USD |
| 2021-09-13 | Mills Kenneth T. | President and CEO | Buy | 3 k | 3,76 | 11 k USD |
| 2021-09-13 | Mills Kenneth T. | President and CEO | Sell | 3 k | 40,02 | 120 k USD |
| 2021-07-27 | Vasista Vittal | Chief Financial Officer | Buy | 10 k | 0,85 | 9 k USD |
| 2021-07-27 | Vasista Vittal | Chief Financial Officer | Buy | 10 k | 0,85 | 9 k USD |
| 2021-06-30 | Danos Olivier | Chief Scientific Officer | Buy | 555 | 33,02 | 18 k USD |
| 2021-06-30 | Danos Olivier | Chief Scientific Officer | Buy | 555 | 33,02 | 18 k USD |
| 2021-06-25 | Mills Kenneth T. | President and CEO | Buy | 2 k | 3,76 | 6 k USD |
| 2021-06-25 | Mills Kenneth T. | President and CEO | Sell | 2 k | 40,25 | 60 k USD |
| 2021-06-25 | Mills Kenneth T. | President and CEO | Buy | 2 k | 3,76 | 6 k USD |
| 2021-06-25 | Mills Kenneth T. | President and CEO | Sell | 2 k | 40,25 | 60 k USD |
| 2021-06-24 | Mills Kenneth T. | President and CEO | Buy | 5 k | 3,76 | 17 k USD |
| 2021-06-24 | Mills Kenneth T. | President and CEO | Sell | 5 k | 40,02 | 180 k USD |
| 2021-06-24 | Mills Kenneth T. | President and CEO | Buy | 5 k | 3,76 | 17 k USD |
| 2021-06-24 | Mills Kenneth T. | President and CEO | Sell | 5 k | 40,02 | 180 k USD |
| 2021-02-25 | Mills Kenneth T. | President and CEO | Buy | 2 k | 0,85 | 1 k USD |
| 2021-02-25 | Mills Kenneth T. | President and CEO | Sell | 2 k | 40,77 | 61 k USD |
| 2021-02-25 | Mills Kenneth T. | President and CEO | Buy | 2 k | 0,85 | 1 k USD |
| 2021-02-25 | Mills Kenneth T. | President and CEO | Sell | 2 k | 40,77 | 61 k USD |
| 2021-02-12 | Christmas Patrick J. | Chief Legal Officer | Buy | 5 k | 12,10 | 57 k USD |
| 2021-02-12 | Christmas Patrick J. | Chief Legal Officer | Sell | 5 k | 49,08 | 231 k USD |
| 2021-02-12 | Christmas Patrick J. | Chief Legal Officer | Buy | 5 k | 12,10 | 57 k USD |
| 2021-02-12 | Christmas Patrick J. | Chief Legal Officer | Sell | 5 k | 49,08 | 231 k USD |
| 2021-02-08 | Christmas Patrick J. | Chief Legal Officer | Buy | 1 k | 12,10 | 16 k USD |
| 2021-02-08 | Christmas Patrick J. | Chief Legal Officer | Sell | 1 k | 49,11 | 64 k USD |
| 2021-02-08 | Christmas Patrick J. | Chief Legal Officer | Buy | 1 k | 12,10 | 16 k USD |
| 2021-02-08 | Christmas Patrick J. | Chief Legal Officer | Sell | 1 k | 49,11 | 64 k USD |
| 2021-02-02 | Christmas Patrick J. | Chief Legal Officer | Buy | 10 k | 12,10 | 121 k USD |
| 2021-02-02 | Christmas Patrick J. | Chief Legal Officer | Sell | 10 k | 44,77 | 425 k USD |
| 2021-02-02 | Christmas Patrick J. | Chief Legal Officer | Sell | 500 | 45,13 | 23 k USD |
| 2021-02-02 | Christmas Patrick J. | Chief Legal Officer | Buy | 10 k | 12,10 | 121 k USD |
| 2021-02-02 | Christmas Patrick J. | Chief Legal Officer | Sell | 10 k | 44,77 | 425 k USD |
| 2021-02-02 | Christmas Patrick J. | Chief Legal Officer | Sell | 500 | 45,13 | 23 k USD |
| 2021-01-25 | Mills Kenneth T. | President and CEO | Buy | 7 k | 0,85 | 6 k USD |
| 2021-01-25 | Mills Kenneth T. | President and CEO | Sell | 315 | 42,64 | 13 k USD |
| 2021-01-25 | Mills Kenneth T. | President and CEO | Sell | 974 | 44,05 | 43 k USD |
| 2021-01-25 | Mills Kenneth T. | President and CEO | Sell | 5 k | 44,99 | 234 k USD |
| 2021-01-25 | Mills Kenneth T. | President and CEO | Buy | 7 k | 0,85 | 6 k USD |
| 2021-01-25 | Mills Kenneth T. | President and CEO | Sell | 315 | 42,64 | 13 k USD |
| 2021-01-25 | Mills Kenneth T. | President and CEO | Sell | 974 | 44,05 | 43 k USD |
| 2021-01-25 | Mills Kenneth T. | President and CEO | Sell | 5 k | 44,99 | 234 k USD |
| 2021-01-15 | Vasista Vittal | Chief Financial Officer | Sell | 252 | 50,04 | 13 k USD |
| 2021-01-15 | Vasista Vittal | Chief Financial Officer | Sell | 252 | 50,04 | 13 k USD |
| 2021-01-14 | Vasista Vittal | Chief Financial Officer | Sell | 11 k | 50,03 | 555 k USD |
| 2021-01-14 | Simpson Curran | Chief Oper. & Tech. Officer | Buy | 1 k | 19,50 | 24 k USD |
| 2021-01-14 | Simpson Curran | Chief Oper. & Tech. Officer | Buy | 10 k | 35,80 | 371 k USD |
| 2021-01-14 | Simpson Curran | Chief Oper. & Tech. Officer | Sell | 12 k | 50,01 | 581 k USD |
| 2021-01-14 | Simpson Curran | Chief Oper. & Tech. Officer | Buy | 1 k | 19,50 | 24 k USD |
| 2021-01-14 | Simpson Curran | Chief Oper. & Tech. Officer | Buy | 10 k | 35,80 | 371 k USD |
| 2021-01-14 | Simpson Curran | Chief Oper. & Tech. Officer | Sell | 12 k | 50,01 | 581 k USD |
| 2021-01-14 | Vasista Vittal | Chief Financial Officer | Sell | 11 k | 50,03 | 555 k USD |
| 2021-01-12 | Vasista Vittal | Chief Financial Officer | Sell | 4 k | 50,01 | 210 k USD |
| 2021-01-12 | Simpson Curran | Chief Oper. & Tech. Officer | Buy | 2 k | 19,50 | 33 k USD |
| 2021-01-12 | Simpson Curran | Chief Oper. & Tech. Officer | Sell | 2 k | 50,03 | 85 k USD |
| 2021-01-12 | Simpson Curran | Chief Oper. & Tech. Officer | Buy | 2 k | 19,50 | 33 k USD |
| 2021-01-12 | Simpson Curran | Chief Oper. & Tech. Officer | Sell | 2 k | 50,03 | 85 k USD |
| 2021-01-12 | Vasista Vittal | Chief Financial Officer | Sell | 4 k | 50,01 | 210 k USD |
| 2021-01-12 | Christmas Patrick J. | Chief Legal Officer | Buy | 1 k | 19,50 | 27 k USD |
| 2021-01-12 | Christmas Patrick J. | Chief Legal Officer | Sell | 1 k | 49,15 | 68 k USD |
| 2021-01-12 | Christmas Patrick J. | Chief Legal Officer | Buy | 1 k | 19,50 | 27 k USD |
| 2021-01-12 | Christmas Patrick J. | Chief Legal Officer | Sell | 1 k | 49,15 | 68 k USD |
| 2021-01-11 | Christmas Patrick J. | Chief Legal Officer | Buy | 8 k | 12,10 | 91 k USD |
| 2021-01-11 | Christmas Patrick J. | Chief Legal Officer | Buy | 3 k | 19,50 | 51 k USD |
| 2021-01-11 | Christmas Patrick J. | Chief Legal Officer | Sell | 10 k | 49,08 | 497 k USD |
| 2021-01-11 | Christmas Patrick J. | Chief Legal Officer | Buy | 8 k | 12,10 | 91 k USD |
| 2021-01-11 | Christmas Patrick J. | Chief Legal Officer | Buy | 3 k | 19,50 | 51 k USD |
| 2021-01-11 | Christmas Patrick J. | Chief Legal Officer | Sell | 10 k | 49,08 | 497 k USD |
| 2021-01-08 | Christmas Patrick J. | Chief Legal Officer | Buy | 10 k | 12,10 | 121 k USD |
| 2021-01-08 | Christmas Patrick J. | Chief Legal Officer | Sell | 5 k | 46,43 | 214 k USD |
| 2021-01-08 | Christmas Patrick J. | Chief Legal Officer | Sell | 4 k | 47,42 | 193 k USD |
| 2021-01-08 | Christmas Patrick J. | Chief Legal Officer | Sell | 1 k | 48,13 | 64 k USD |
| 2021-01-08 | Christmas Patrick J. | Chief Legal Officer | Buy | 10 k | 12,10 | 121 k USD |
| 2021-01-08 | Christmas Patrick J. | Chief Legal Officer | Sell | 5 k | 46,43 | 214 k USD |
| 2021-01-08 | Christmas Patrick J. | Chief Legal Officer | Sell | 4 k | 47,42 | 193 k USD |
| 2021-01-08 | Christmas Patrick J. | Chief Legal Officer | Sell | 1 k | 48,13 | 64 k USD |
| 2021-01-08 | Vasista Vittal | Chief Financial Officer | Sell | 2 k | 46,45 | 114 k USD |
| 2021-01-08 | Vasista Vittal | Chief Financial Officer | Sell | 2 k | 47,49 | 105 k USD |
| 2021-01-08 | Vasista Vittal | Chief Financial Officer | Sell | 573 | 48,15 | 28 k USD |
| 2021-01-08 | Vasista Vittal | Chief Financial Officer | Sell | 2 k | 46,45 | 114 k USD |
| 2021-01-08 | Vasista Vittal | Chief Financial Officer | Sell | 2 k | 47,49 | 105 k USD |
| 2021-01-08 | Vasista Vittal | Chief Financial Officer | Sell | 573 | 48,15 | 28 k USD |
| 2021-01-07 | Mills Kenneth T. | President and CEO | Buy | 2 k | 0,85 | 1 k USD |
| 2021-01-07 | Mills Kenneth T. | President and CEO | Sell | 2 k | 50,01 | 75 k USD |
| 2021-01-07 | Mills Kenneth T. | President and CEO | Buy | 2 k | 0,85 | 1 k USD |
| 2021-01-07 | Mills Kenneth T. | President and CEO | Sell | 2 k | 50,01 | 75 k USD |
| 2021-01-07 | Vasista Vittal | Chief Financial Officer | Sell | 11 k | 50,00 | 550 k USD |
| 2021-01-07 | Simpson Curran | Chief Oper. & Tech. Officer | Buy | 5 k | 19,50 | 101 k USD |
| 2021-01-07 | Simpson Curran | Chief Oper. & Tech. Officer | Sell | 5 k | 50,01 | 259 k USD |
| 2021-01-07 | Simpson Curran | Chief Oper. & Tech. Officer | Buy | 5 k | 19,50 | 101 k USD |
| 2021-01-07 | Simpson Curran | Chief Oper. & Tech. Officer | Sell | 5 k | 50,01 | 259 k USD |
| 2021-01-07 | Vasista Vittal | Chief Financial Officer | Sell | 11 k | 50,00 | 550 k USD |
| 2021-01-04 | Christmas Patrick J. | Chief Legal Officer | Buy | 14 k | 0,00 | 0 USD |
| 2021-01-04 | Danos Olivier | Chief Scientific Officer | Buy | 12 k | 0,00 | 0 USD |
| 2021-01-04 | Mills Kenneth T. | President and CEO | Buy | 41 k | 0,00 | 0 USD |
| 2021-01-04 | PAKOLA STEVE | Chief Medical Officer | Buy | 11 k | 0,00 | 0 USD |
| 2021-01-04 | Mills Kenneth T. | President and CEO | Buy | 41 k | 0,00 | 0 USD |
| 2021-01-04 | Christmas Patrick J. | Chief Legal Officer | Buy | 14 k | 0,00 | 0 USD |
| 2021-01-04 | Danos Olivier | Chief Scientific Officer | Buy | 12 k | 0,00 | 0 USD |
| 2021-01-04 | PAKOLA STEVE | Chief Medical Officer | Buy | 11 k | 0,00 | 0 USD |
| 2021-01-04 | Simpson Curran | Chief Oper. & Tech. Officer | Buy | 14 k | 0,00 | 0 USD |
| 2021-01-04 | Vasista Vittal | Chief Financial Officer | Buy | 12 k | 0,00 | 0 USD |
| 2021-01-04 | Simpson Curran | Chief Oper. & Tech. Officer | Buy | 14 k | 0,00 | 0 USD |
| 2021-01-04 | Vasista Vittal | Chief Financial Officer | Buy | 12 k | 0,00 | 0 USD |
| 2020-12-28 | Mills Kenneth T. | President and CEO | Buy | 7 k | 0,85 | 6 k USD |
| 2020-12-28 | Mills Kenneth T. | President and CEO | Sell | 5 k | 48,47 | 225 k USD |
| 2020-12-28 | Mills Kenneth T. | President and CEO | Sell | 2 k | 49,16 | 91 k USD |
| 2020-12-28 | Mills Kenneth T. | President and CEO | Buy | 7 k | 0,85 | 6 k USD |
| 2020-12-28 | Mills Kenneth T. | President and CEO | Sell | 5 k | 48,47 | 225 k USD |
| 2020-12-28 | Mills Kenneth T. | President and CEO | Sell | 2 k | 49,16 | 91 k USD |
| 2020-12-24 | Vasista Vittal | Chief Financial Officer | Sell | 3 k | 50,00 | 169 k USD |
| 2020-12-24 | Vasista Vittal | Chief Financial Officer | Sell | 3 k | 50,00 | 169 k USD |
| 2020-12-23 | Mills Kenneth T. | President and CEO | Buy | 5 k | 0,85 | 4 k USD |
| 2020-12-23 | Mills Kenneth T. | President and CEO | Sell | 5 k | 50,00 | 225 k USD |
| 2020-12-23 | Mills Kenneth T. | President and CEO | Buy | 5 k | 0,85 | 4 k USD |
| 2020-12-23 | Mills Kenneth T. | President and CEO | Sell | 5 k | 50,00 | 225 k USD |
| 2020-12-23 | Vasista Vittal | Chief Financial Officer | Sell | 21 k | 50,01 | 1.1 mn USD |
| 2020-12-23 | Vasista Vittal | Chief Financial Officer | Sell | 21 k | 50,01 | 1.1 mn USD |
| 2020-12-16 | Mills Kenneth T. | President and CEO | Buy | 15 k | 0,85 | 13 k USD |
| 2020-12-16 | Mills Kenneth T. | President and CEO | Sell | 15 k | 45,00 | 675 k USD |
| 2020-12-16 | Mills Kenneth T. | President and CEO | Buy | 15 k | 0,85 | 13 k USD |
| 2020-12-16 | Mills Kenneth T. | President and CEO | Sell | 15 k | 45,00 | 675 k USD |
| 2020-12-11 | Vasista Vittal | Chief Financial Officer | Sell | 15 k | 40,17 | 599 k USD |
| 2020-12-11 | Vasista Vittal | Chief Financial Officer | Sell | 15 k | 40,17 | 599 k USD |
| 2020-12-10 | Mills Kenneth T. | President and CEO | Buy | 5 k | 0,85 | 4 k USD |
| 2020-12-10 | Mills Kenneth T. | President and CEO | Sell | 5 k | 40,00 | 180 k USD |
| 2020-12-10 | Mills Kenneth T. | President and CEO | Buy | 5 k | 0,85 | 4 k USD |
| 2020-12-10 | Mills Kenneth T. | President and CEO | Sell | 5 k | 40,00 | 180 k USD |
| 2020-12-10 | Vasista Vittal | Chief Financial Officer | Sell | 23 k | 40,06 | 905 k USD |
| 2020-12-10 | Vasista Vittal | Chief Financial Officer | Sell | 23 k | 40,06 | 905 k USD |
| 2020-08-06 | Fox Allan M. | Director | Sell | 90 k | 0,00 | 0 USD |
| 2020-08-06 | Fox Allan M. | Director | Buy | 90 k | 0,00 | 0 USD |
| 2020-08-06 | Fox Allan M. | Director | Sell | 90 k | 0,00 | 0 USD |
| 2020-08-06 | Fox Allan M. | Director | Buy | 90 k | 0,00 | 0 USD |
| 2020-07-27 | Fox Allan M. | Director | Sell | 225 k | 0,00 | 0 USD |
| 2020-07-27 | Fox Allan M. | Director | Buy | 225 k | 0,00 | 0 USD |
| 2020-07-27 | Fox Allan M. | Director | Sell | 225 k | 0,00 | 0 USD |
| 2020-07-27 | Fox Allan M. | Director | Buy | 225 k | 0,00 | 0 USD |
| 2020-07-15 | Vasista Vittal | Chief Financial Officer | Buy | 3 k | 13,09 | 43 k USD |
| 2020-07-15 | Vasista Vittal | Chief Financial Officer | Sell | 15 k | 40,10 | 599 k USD |
| 2020-07-15 | Vasista Vittal | Chief Financial Officer | Buy | 3 k | 13,09 | 43 k USD |
| 2020-07-15 | Vasista Vittal | Chief Financial Officer | Sell | 15 k | 40,10 | 599 k USD |
| 2020-06-30 | Danos Olivier | Chief Scientific Officer | Buy | 641 | 31,31 | 20 k USD |
| 2020-06-30 | Danos Olivier | Chief Scientific Officer | Buy | 641 | 31,31 | 20 k USD |
| 2019-12-31 | Danos Olivier | Chief Scientific Officer | Buy | 302 | 34,82 | 11 k USD |
| 2019-12-31 | Danos Olivier | Chief Scientific Officer | Buy | 302 | 34,82 | 11 k USD |